PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study shows promise for preventing therapy resistance in tumor cells

2014-01-10
(Press-News.org) Contact information: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky
New study shows promise for preventing therapy resistance in tumor cells LEXINGTON, Ky. (Jan. 9, 2013) – A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer cells. This finding may help researchers decipher how to inhibit the growth of tumors that have become resistant to other treatments.

Loss of the tumor suppressor p53 often contributes to therapy resistance in tumors. In the study, published in Cell Reports, the University of Kentucky's Vivek Rangnekar and his colleagues activated wild type p53 in normal cells to trigger cell death in the p53-deficient cancer cells. Because p53 is intact and functional in normal cells, the researchers harnessed its potential to inhibit the growth of p53-deficient cancer cells.

This paracrine effect was brought about by the tumor suppressor Par-4, which specifically kills cancer cells. Although other tumor suppressors exist, what makes Par-4 so special is that it is not mutated as frequently as other known suppressors, and it's "selective" in its actions in that Par-4 will only kill cancer cells and not normal cells. Importantly, it's secretion from normal cells can be induced by activating p53 so that Par-4 enters circulation, thereby potentially targeting tumor cells at distant sites.

"As normal cells far outnumber the cancer cells in patients, we sought to empower the normal cells to trigger cell death in p53-deficient cancer cells," said Rangnekar, associate director of transdisciplinary collaborations for the UK Markey Cancer Center. "Our findings have potential for targeting local, as well as metastatic tumors, and future studies will use FDA-approved drugs to induce Par-4 secretion."

INFORMATION:

The UK Markey Cancer Center is the only National Cancer Institute-designated cancer center in Kentucky. NCI-designated cancer centers are a major source of discovery and development of more effective approaches to cancer prevention, diagnosis and treatment. Rangnekar, a professor in the department of radiation medicine, also holds the Alfred Cohen Endowed Chair in Oncology Research.

END



ELSE PRESS RELEASES FROM THIS DATE:

Innovative motion evaluation tool saves patients with back pain X-ray radiation exposure

2014-01-10
Innovative motion evaluation tool saves patients with back pain X-ray radiation exposure Undergraduate students create, patent, market breakthrough technology TAMPA, Fla. (Jan. 9, 2013) – Those have undergone extensive back surgery and need repeated ...

'Transformational leadership' curbs bad attitudes towards change

2014-01-10
'Transformational leadership' curbs bad attitudes towards change Rare study of correctional officers Toronto – It's no surprise that a cynical attitude towards the prospect of change makes change harder to implement. But it's important ...

War elephant myths debunked by DNA

2014-01-10
War elephant myths debunked by DNA DNA analysis allows researchers at University of Illinois to clarify details of historic battle between Asian and African elephants, the Battle of Raphia Through DNA analysis, Illinois researchers ...

Battery development may extend range of electric cars

2014-01-10
Battery development may extend range of electric cars New anode quadruples life of lithium-sulfur battery, could also help store renewable energy more cheaply RICHLAND, Wash. – It's known that electric vehicles could travel longer distances ...

Antipsychotic drug exhibits cancer-fighting properties

2014-01-10
Antipsychotic drug exhibits cancer-fighting properties In zebrafish model, perphenazine activates therapeutic pathway for intractable leukemia, may hold promise for other tumors BOSTON, Jan. 9, 2014 - In a prime example of finding new uses for older ...

Some motor proteins cooperate better than others

2014-01-10
Some motor proteins cooperate better than others Rice University researchers view competition, cooperation among motors in live cells HOUSTON - (Jan. 9, 2014) - Rice University researchers have engineered cells to characterize how sensitively altering the cooperative functions of ...

ORNL-UT researchers invent 'sideways' approach to 2-D hybrid

2014-01-10
ORNL-UT researchers invent 'sideways' approach to 2-D hybrid OAK RIDGE, Tenn., Jan. 9, 2014 -- Researchers at the Department of Energy's Oak Ridge National Laboratory and the University of Tennessee, Knoxville have pioneered a new technique for forming ...

Hubble probes interior of Tarantula Nebula

2014-01-10
Hubble probes interior of Tarantula Nebula Like lifting a giant veil, the near-infrared vision of NASA's Hubble Space Telescope uncovers a dazzling new view deep inside the Tarantula Nebula. Hubble reveals a glittering treasure trove of more than ...

Hubble views stellar genesis in the Southern Pinwheel

2014-01-10
Hubble views stellar genesis in the Southern Pinwheel A photogenic and favorite target for amateur astronomers, the full beauty of nearby barred spiral galaxy M83 is unveiled in all of its glory in this Hubble Space Telescope mosaic image. The ...

Novel biomarker approach suggests new avenues to improve schizophrenia disease management

2014-01-10
Novel biomarker approach suggests new avenues to improve schizophrenia disease management Environmental effects of events such as oxygen deprivation and infections may be preserved as markers in blood that are associated to schizophrenia, according to an ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New study shows promise for preventing therapy resistance in tumor cells